Ceritinib 150 Mg Capsules

Description

ZYKADIA (Cerinib 150mg) is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC) that: Is caused by a defect in a gene called anaplastic lymphoma kinase (ALK) and has spread to other parts of the body It is not known if ZYKADIA is safe and effective in children. IMPORTANT SAFETY INFORMATION ABOUT ZYKADIA What is the most important information I should know about ZYKADIA? ZYKADIA may cause serious side effects, such as: Stomach and intestinal (gastrointestinal) problems ZYKADIA may cause stomach and intestinal problems, including diarrhea, nausea, vomiting, and stomach-area pain. Follow your health care provider’s instructions about taking medicines to help with these symptoms. Call your health care provider for advice if your symptoms are severe or cannot be tolerated Liver problems ZYKADIA may cause liver injury. Your health care provider should perform blood tests at least every month to check your liver during treatment with ZYKADIA. Tell your health care provider right away if you experience any of the following symptoms: You feel tired Your skin or the whites of your eyes turn yellow You have a decreased appetite Your urine turns dark or brown (tea color) You have itchy skin You have nausea or vomiting You have pain on the right side of your stomach area You bleed or bruise more easily than normal Lung problems (pneumonitis) ZYKADIA may cause severe or life-threatening swelling (inflammation) of the lungs during treatment that can lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your health care provider right away if you have any new or worsening symptoms, including: Trouble breathing or shortness of breath Cough, with or without mucus Fever Chest pain Heart problems ZYKADIA may cause very slow, very fast, or abnormal heartbeats. Your health care provider may check your heart during treatment with ZYKADIA. Tell your health care provider right away if you feel new chest pain or discomfort, dizziness or lightheadedness, faint, or have abnormal heartbeats. Tell your health care provider if you start to take or have any changes in heart or blood pressure medicines High blood sugar (hyperglycemia) People who have diabetes or glucose intolerance or those who take a corticosteroid medicine have an increased risk of high blood sugar with ZYKADIA. Your health care provider will check your blood sugar level before starting ZYKADIA and as needed during treatment with ZYKADIA. Call your health care provider right away if you have any symptoms of high blood sugar, including: Increased thirst Urinating often Increased hunger Blurred vision Headaches Tiredness Trouble thinking or concentrating Your breath smells like fruit Inflammation of the pancreas (pancreatitis) ZYKADIA can cause pancreatitis that has led to death. You may develop increased pancreatic enzyme blood levels, which may be a sign of pancreatitis. Signs and symptoms of pancreatitis include upper abdominal pain that may spread to the back and get worse with eating. Your health care provider should perform blood tests to check your pancreatic enzyme blood levels before you start ZYKADIA and as needed during your treatment Before you take ZYKADIA, tell your health care provider about all of your medical conditions, including if you: have liver problems have diabetes or high blood sugar have heart problems, including a condition called long QT syndrome have or have had pancreatitis are pregnant or plan to become pregnant. ZYKADIA can harm your unborn baby. Women who are able to become pregnant should use an effective method of birth control during treatment with ZYKADIA and for 6 months after stopping ZYKADIA. Talk to your health care provider about birth control methods that may be right for you. Tell your health care provider right away if you become pregnant or think that you may be pregnant